Tag: USCR News

Business

Arbutus Biopharma Corp (NASDAQ: ABUS) Receives A Nod To Investigate New Drug, Rosen Law Firm Issues Loss Alert, Halper Sadeh LLP Initiates Investigating Companies

Arbutus Biopharma Corp (NASDAQ: ABUS) is back in the news. First, the company announced that it had received a go-ahead from the U.S. Food and Drug Administration to investigate New Drug (IND) application for AB-729 in a Phase 2a clinical trial. The Phase 2a proof-of-concept clinical trial will evaluate the […]

Business

DiDi Global Inc – ADR (NYSE: DIDI) Is Under Investigation By A Law Firm, And Other Companies Also Under The Scanner For Violation Of Security Laws

DiDi Global Inc – ADR (NYSE: DIDI) is under the scanner for alleged violation of security laws. In a statement, the Schall Law Firm, a national shareholder rights litigation firm, announced that the law firm had initiated an investigation against the company on behalf of investors.  The focus of the […]